Marina Landsberg

Product: Luspatercept and Pomalidomide

• Operating across the entire Brazilian territory, focusing on diseases such as Multiple myeloma and Myelodysplastic syndromes.
• Visiting key opinion leader physicians, providing brand support and clinical research assistance.
• Involved in the development of new molecules in the Hematology pipeline, specifically with Mezigdomide, Iberdomide, Luspatercept, Golcadomide.
• Direct involvement in generating insights, connecting with the global team, and capturing insights that drive local action.
• Skills: Scientific communication, stakeholder relationship management, clinical study support, clinical data analysis, insight generation, global team collaboration.

• Responsible for the territories of Minas Gerais and Espírito Santo, working with diseases such as Multiple myeloma, Follicular lymphoma, Marginal zone lymphoma, and Mantle cell lymphoma.
• Promoted the medication Revlimid (Lenalidomide)
• Skills: Sales strategies, territory management, client relationship development, in-depth product and disease knowledge.

• Operated in Minas Gerais, promoting the immunobiologic Orencia (abatacept) for the treatment of rheumatoid arthritis and juvenile idiopathic arthritis (JIA)
• Skills: Medical education, market development, technical-scientific support, negotiation skills

• Promoted the medication Adalimumab for indications of Crohn's disease and ulcerative colitis
• Served gastroenterologists and colorectal surgeons
• Skills: Knowledge of gastrointestinal diseases, sales strategy development, relationship building with healthcare professionals

• Developed technical work focused on hospital enteral nutrition
• Skills: Technical support, nutritional education, development of nutritional protocols, patient care in hospital settings